To determine the beneficial and harmful effects of glucocorticoids for reducing PONV or both in patients undergoing laparoscopic cholecystectomy relative to placebo or alternative antiemetic agents.
This is a protocol.
Glucocorticosteroids for patients undergoing laparoscopic cholecystectomy
You may also be interested in:
- Different methods of cystic duct occlusion in patients undergoing laparoscopic cholecystectomy
- Drains increase the harms to patients undergoing open cholecystectomy
- Routine abdominal drainage versus no drainage for patients undergoing uncomplicated laparoscopic cholecystectomy
- Formal education of patients about to undergo laparoscopic cholecystectomy
- Robot assistant versus human or another robot assistant in patients undergoing laparoscopic cholecystectomy
Health topics: